These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7673606)

  • 1. Proceedings of the 2nd International Colloquium on Proton Pump Inhibitors.
    J Clin Gastroenterol; 1995; 20 Suppl 1():S1-51. PubMed ID: 7673606
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of Acid Secretion by Lansoprazole and its Effects on Helicobacter pylori. II. Poster presentations from the 2nd International Colloquium on Proton Pump Inhibitors. Houston, Texas, September 29, 1994.
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-135. PubMed ID: 7594319
    [No Abstract]   [Full Text] [Related]  

  • 3. Determinants of non-response in Helicobacter pylori eradication trials.
    Klotz U; Treiber G; Schwab M
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1471. PubMed ID: 16105147
    [No Abstract]   [Full Text] [Related]  

  • 4. Helicobacter pylori eradication increases nocturnal acid breakthrough.
    van Herwaarden MA; Samsom M; Smout AJ
    Aliment Pharmacol Ther; 2000 Jul; 14(7):961-2. PubMed ID: 10886054
    [No Abstract]   [Full Text] [Related]  

  • 5. Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective.
    Furuta T; Shirai N; Sugimoto M; Ohashi K; Ishizaki T
    Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1175-6. PubMed ID: 14653841
    [No Abstract]   [Full Text] [Related]  

  • 6. Continued use of the proton-pump inhibitor lansoprazole following Helicobacter pylori eradication.
    Claessens AA; Heerdink ER; van Eijk JT; Lamers CB; Leufkens HG
    Eur J Clin Pharmacol; 2000 Jan; 55(10):773-6. PubMed ID: 10663458
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori: factors affecting eradication and recurrence.
    Vakil N
    Am J Gastroenterol; 2005 Nov; 100(11):2393-4. PubMed ID: 16279890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of proton pump inhibitors].
    Herszényi L; Tulassay Z
    Orv Hetil; 2001 Sep; 142(36):1953-61. PubMed ID: 11680100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which proton pump inhibitor should we use?
    Williams CN
    Can J Gastroenterol; 1997; 11(1):29. PubMed ID: 9113794
    [No Abstract]   [Full Text] [Related]  

  • 10. Eradication of H. pylori in a developing country: comparison of lansoprazole versus omeprazole with norfloxacin, in a dual-therapy study.
    Gupta VK; Dhar A; Srinivasan S; Rattan A; Sharma MP
    Am J Gastroenterol; 1997 Jul; 92(7):1140-2. PubMed ID: 9219786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M; Figura N
    J Clin Gastroenterol; 1998; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of a proton pump inhibitor-based therapy on Helicobacter pylori strain selection.
    Hazell SL; Mitchell HM; Hanna G; Daskalopoulos G
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):530-2. PubMed ID: 9272389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Helicobacter pylori eradication: modified triple therapy with lansoprazole].
    Müller P; Simon B
    Fortschr Med; 1996 Dec; 114(35-36):497-9. PubMed ID: 9119351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPI-based triple therapy in the eradication of H. pylori infection.
    Savarino V; Neri M; Vigneri S
    Gastroenterology; 1999 Sep; 117(3):746-7. PubMed ID: 10490365
    [No Abstract]   [Full Text] [Related]  

  • 16. [What are the indications for proton pump inhibitors? R. Arnold, Marburg, elaborates on the clinical aspects of the controversy regarding lansoprazole. Interview by Gerrit Lichtenberg].
    Arnold R
    Fortschr Med; 1994 Jan; 112(1-2):44-5. PubMed ID: 8144120
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori].
    Kawata H; Satoh K
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():640-4. PubMed ID: 11979862
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
    Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Masking of 13C urea breath test by proton pump inhibitors is dependent on type of medication: comparison between omeprazole, pantoprazole, lansoprazole and esomeprazole.
    Levine A; Shevah O; Shabat-Sehayek V; Aeed H; Boaz M; Moss SF; Niv Y; Avni Y; Shirin H
    Aliment Pharmacol Ther; 2004 Jul; 20(1):117-22. PubMed ID: 15225178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.